PEspeaks

Mar 05, 2015
In reaction to AbbVie’s massive acquisition of Pharmacyclics, investors who were caught unprepared are looking for ways they could have predicted the deal. Casey McDonald looks at the reaction on Twitter.
Mar 04, 2015
Will the EU's proposed STAMP halt its progress on MAPPs (medicine adaptive pathways to patients)? Reflector reports.
Mar 03, 2015
How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality. Lundbeck's Timothy White reports.
Pharmaceutical Executive Europe: Mar 02, 2015
The debate around NICE's threshold for cost effectiveness has always been heated; recent theories add more fuel to the fire, writes Leela Barham.
Mar 02, 2015
The Jim Carrey film Liar Liar showed us the comic consequences of always telling the truth. What if people in business did the same? Mike Straw considers what the impact on pharma would be.
Feb 27, 2015
Thanks to Shire's star drug Vyvanse, if you don't know much about binge-eating disorder, you soon will, writes Marylyn Donahue.
Feb 25, 2015
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers and biopharma manufacturers, writes Jill Wechsler.
Applied Clinical Trials: Feb 22, 2015
Moe Alsumidaie looks at data collection methods and concepts that can result in predicting patients at risk of dropping out from a clinical trial.
Feb 12, 2015
The European Commission’s (EC) decision to withdraw its investigation into the UK Government's Patent Box scheme is positive news for British innovators, writes Michael Jaeger.
Feb 12, 2015
The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high U.S. revenues to fund biopharmaceutical R&D, writes Jill Wechsler.